Kewaunee Scientific Corporation
KEQU
$41.53
-$1.61-3.73%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 46.93% | 36.06% | 43.59% | -5.30% | -2.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.93% | 36.06% | 43.59% | -5.30% | -2.90% |
| Cost of Revenue | 39.74% | 26.27% | 40.40% | -8.54% | -5.33% |
| Gross Profit | 67.60% | 64.19% | 52.79% | 3.59% | 4.82% |
| SG&A Expenses | 62.61% | 70.41% | 95.17% | 13.32% | 21.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.69% | 34.13% | 50.92% | -4.49% | -0.55% |
| Operating Income | 86.80% | 53.93% | -40.24% | -12.53% | -31.64% |
| Income Before Tax | 61.32% | 430.73% | -63.73% | -18.86% | -28.78% |
| Income Tax Expenses | 296.35% | 122.40% | -111.00% | -54.54% | -78.60% |
| Earnings from Continuing Operations | 41.15% | -55.75% | -45.40% | 6.54% | -11.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -46.67% | 36.60% | -141.67% | 92.86% | -9.76% |
| Net Income | 41.04% | -56.01% | -46.29% | 10.10% | -11.36% |
| EBIT | 86.80% | 53.93% | -40.24% | -12.53% | -31.64% |
| EBITDA | 87.58% | 54.46% | -16.78% | -10.26% | -24.41% |
| EPS Basic | 40.95% | -55.95% | -45.90% | 11.30% | -11.02% |
| Normalized Basic EPS | 61.65% | 36.76% | -64.59% | -15.49% | -29.26% |
| EPS Diluted | 40.54% | -56.06% | -47.06% | 8.60% | -13.95% |
| Normalized Diluted EPS | 61.99% | 36.15% | -65.21% | -17.60% | -31.49% |
| Average Basic Shares Outstanding | 0.07% | -0.14% | -0.73% | -1.07% | -0.38% |
| Average Diluted Shares Outstanding | -0.13% | 0.30% | 1.01% | 1.47% | 2.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |